Silberstein

Burns & Levinson Partner Debra Rahmin Silberstein Elected to National Academy of Elder Law Attorneys Board

Retrieved on: 
Thursday, January 12, 2023

BOSTON, Jan. 12, 2023 /PRNewswire/ -- Burns & Levinson announced today that Debra Silberstein, Ph.D. , a partner in the firm's industry-leading Private Client Group, has been elected to the Board of Directors of the National Academy of Elder Law Attorneys Massachusetts Chapter (MassNAELA).

Key Points: 
  • BOSTON, Jan. 12, 2023 /PRNewswire/ -- Burns & Levinson announced today that Debra Silberstein, Ph.D. , a partner in the firm's industry-leading Private Client Group, has been elected to the Board of Directors of the National Academy of Elder Law Attorneys Massachusetts Chapter (MassNAELA).
  • Silberstein has more than 30 years of experience working with clients to navigate a wide range of trusts and estates, family philanthropic planning, tax, and elder law matters.
  • She received the 2018 Powley Elder Law Award from the National Academy of Elder Law Attorneys for her impressive contributions to the field.
  • Silberstein was also named a "Family/Elder Law Trailblazer" by The National Law Journal in 2022.

ASK4SAM Launches New York Camp Lejeune Toxic Water Legal Injury Claims Hotline

Retrieved on: 
Friday, September 9, 2022

Silberstein, Awad, and Miklos, P.C. (ASK4SAM) has recently sponsored a toll free hotline number for New York residents who have been affected by the Camp Lejeune Toxic Water Contamination and who want to speak with an attorney at no cost about their potential claim.

Key Points: 
  • (ASK4SAM) has launched a Camp Lejeune Toxic Water Injury Claims Hotline to help residents of New York State seek compensation for themselves or their loved ones if they stationed at Camp Lejeune and were harmed by the toxic water that plagued the Marine Corps Base Camp Lejeune in Jacksonville, NC, which is in Eastern North Carolina during the qualified span of time discussed below.
  • Residents of New York State can call this number and speak to an attorney about whether they have a claim in the recently decided Camp Lejeune contaminated water supply case.
  • For New York Residents or their loved ones who were stationed at Camp Lejeune for a period of 30 days or longer are elligible to call the New York State Camp Lejeune Toxic Water Injury Claims Hotline , by calling 888-6-LEJEUNE, or by visiting ask4sam.net and clicking on the Camp Lejeune Claims option on the main page, or clicking the link in the description below to learn more about this civil claim about the contaminated drinking water on the base.
  • They have multiple office locations across New York City, and they set up the Camp Lejeune Toxic Water Injury Claim Hotline to help further streamline the fair compensation and disability benefits for those exposed to toxic materials on the military base.

Silberstein, Awad & Miklos: Amidst the Courtroom's New Reality, Jury Awards 20.7 Million in Largest Medical Malpractice Verdict in Manhattan Since Civil Trials Resumed

Retrieved on: 
Monday, August 15, 2022

NEW YORK, Aug. 15, 2022 /PRNewswire-PRWeb/ -- On April 12, 2022, a New York County jury at the Supreme Court of the State of New York County of New York: Civil Term: Part 4, Case number 805366/2016, reported a verdict that neurosurgeon Robert Snow of Weill Cornell and New York Hospital deviated from accepted medical practice by not diagnosing postoperative infection by failing to order repeat blood tests and MRI. The jury verdict for damages was eight million for past pain and suffering (eight years); four million five hundred thousand for future pain and suffering (32 years); six million four hundred thousand for past lost earnings; and future lost earnings of one million eight hundred thousand.

Key Points: 
  • case is the largest medical malpractice verdict in the state (20.7 million) since the Covid-19 lockdown of March 2020.
  • It is also the largest sum awarded for pain and suffering for osteomyelitis in the state of New York.
  • Jury verdict's award is the largest medical malpractice verdict in the state (20.7 million) since the Covid-19 lockdown of March 2020.
  • It is also the largest sum awarded for pain and suffering for osteomyelitis in the state of New York.

Teva Announces Promising Interim Results From Its Study PEARL, About the Impact of AJOVY® (fremanezumab)

Retrieved on: 
Friday, June 24, 2022

AJOVY is available as a 225 mg/1.5 mL single dose injection in a pre-filled syringe or, in some countries, in a pre-filled pen.

Key Points: 
  • AJOVY is available as a 225 mg/1.5 mL single dose injection in a pre-filled syringe or, in some countries, in a pre-filled pen.
  • AJOVY can be administered either by a healthcare professional or at home by a patient or caregiver.
  • Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has been developing and producing medicines to improve peoples lives for more than a century.
  • (v0.1) - The two year Pan-European Real World (PEARL) prospective, observational study of AJOVY (fremanezumab)
    2 KPMG, prepared for the European Migraine and Headache Alliance (EMHA).

3 Greenberg Traurig Attorneys Named Law360 Rising Stars

Retrieved on: 
Wednesday, June 1, 2022

NEW YORK, May 31, 2022 /PRNewswire-PRWeb/ -- Michael H. Davis, Ashley M. Farrell Pickett, and Daniella G. Silberstein, shareholders at global law firm Greenberg Traurig, LLP, have been named to Law360's Rising Stars list for 2022. The three attorneys were among 176 lawyers recognized out of 1,350 submissions, across 36 practices. The list honors attorneys under age 40 "whose legal accomplishments transcend their age," according to the publication.

Key Points: 
  • Michael H. Davis, Ashley M. Farrell Pickett, and Daniella G. Silberstein, shareholders at global law firm Greenberg Traurig, LLP, have been named to Law360's Rising Stars list for 2022.
  • NEW YORK, May 31, 2022 /PRNewswire-PRWeb/ -- Michael H. Davis , Ashley M. Farrell Pickett , and Daniella G. Silberstein , shareholders at global law firm Greenberg Traurig, LLP, have been named to Law360's Rising Stars list for 2022.
  • Davis, a shareholder in the Los Angeles office, was named a Real Estate Rising Star.
  • About Greenberg Traurig: Greenberg Traurig, LLP has more than 2400 attorneys in 43 locations in the United States, Europe, Latin America, Asia, and the Middle East.

Burns & Levinson Partner Debra Rahmin Silberstein Named "Family/Elder Law Trailblazer" by The National Law Journal

Retrieved on: 
Monday, April 4, 2022

BOSTON, April 4, 2022 /PRNewswire/ -- Burns & Levinson announced today that Debra Silberstein, Ph.D. , a partner in the firm's industry-leading Private Client Group, has been named a "Family/Elder Law Trailblazer" byThe National Law Journal (NLJ)for her leadership role in estate planning for families and elders.

Key Points: 
  • BOSTON, April 4, 2022 /PRNewswire/ -- Burns & Levinson announced today that Debra Silberstein, Ph.D. , a partner in the firm's industry-leading Private Client Group, has been named a "Family/Elder Law Trailblazer" byThe National Law Journal (NLJ)for her leadership role in estate planning for families and elders.
  • Silberstein has more than 30 years of experience working with clients to navigate a wide range of trusts and estates, family philanthropic planning, tax, and elder law matters.
  • She received the 2018 Powley Elder Law Award from the National Academy of Elder Law Attorneys for her impressive contributions to the field.
  • At Burns & Levinson, we provide high-level, client-centric and results-oriented legal services to our regional, national and international clients.

Applied Therapeutics Announces Appointment of Dr. Chuck Silberstein, MD, MBA, CFA as Chief Financial Officer and Head of Business Development

Retrieved on: 
Tuesday, May 26, 2020

Dr. Silberstein is replacing Dr. Mark Vignola, who will be moving on to pursue new business opportunities.

Key Points: 
  • Dr. Silberstein is replacing Dr. Mark Vignola, who will be moving on to pursue new business opportunities.
  • His experience across all aspects of the business, including corporate strategy and business development, solidifies our capabilities as we move forward.
  • Dr. Silberstein was formerly Senior Vice President of Corporate Business Development at Allergan plc (recently acquired by AbbVie).
  • Dr. Silberstein received his MD from Albert Einstein College of Medicine and his MBA from Columbia Business School.

EK's Kat Silberstein Promoted to Chief Executive Officer of the Americas

Retrieved on: 
Wednesday, July 17, 2019

SAN ANTONIO, July 17, 2019 /PRNewswire-PRWeb/ --EK (EKWB), a leading premium liquid cooling solutions provider, announces today that effective immediately Kat Silberstein has been promoted to the role of Chief Executive Officer for the Americas.

Key Points: 
  • SAN ANTONIO, July 17, 2019 /PRNewswire-PRWeb/ --EK (EKWB), a leading premium liquid cooling solutions provider, announces today that effective immediately Kat Silberstein has been promoted to the role of Chief Executive Officer for the Americas.
  • In her new position, Silberstein will contribute to their long-term global growth strategy, while managing the U.S., Canada, and Latin America operations.
  • This promotion was part of the global brand initiative to accelerate EK's fast growth in the Americas.
  • With Silberstein at the helm, the company will continue to expand its distribution base while solidifying key strategic industry and partner alliances.

NeurologyLive™ Names Stephen D. Silberstein as Editor In Chief

Retrieved on: 
Wednesday, April 10, 2019

NeurologyLive, a multimedia platform dedicated to providing health care professionals treating neurological diseases with direct access to expert-driven, practice-changing news and insights in neurology, welcomes Stephen D. Silberstein, M.D., as its new editor in chief.

Key Points: 
  • NeurologyLive, a multimedia platform dedicated to providing health care professionals treating neurological diseases with direct access to expert-driven, practice-changing news and insights in neurology, welcomes Stephen D. Silberstein, M.D., as its new editor in chief.
  • We look forward to having Dr. Silberstein join the NeurologyLive team, said Michael J. Hennessy Jr., president of MJH Associates, Inc., parent company of NeurologyLive.
  • As one of the leading experts in neurology, Silberstein brings more than 40 years of distinguished medical service to the role.
  • NeurologyLive is part of the Cranbury, New Jersey-based MJH Associates, Inc. family of businesses, which includes OncLive and CURE magazine.

FS-ISAC Names Steven Silberstein New CEO

Retrieved on: 
Tuesday, December 4, 2018

Silberstein will replace outgoing CEO Bill Nelson January 1, 2019

Key Points: 
  • Silberstein will replace outgoing CEO Bill Nelson January 1, 2019
    The Financial Services Information Sharing and Analysis Center (FS-ISAC) , today announced the appointment of Steven Silberstein as President and Chief Executive Officer (CEO).
  • In his new role, Silberstein will be responsible for expanding FS-ISAC membership and its products, services and resources, while continuing to embody its non-profit mission.
  • He will lead efforts to increase the value of information sharing in the sector and improve how member organizations share critical information.
  • Silberstein joins FS-ISAC from BlueVoyant, where he was chief operating officer, responsible for technology, marketing and administration of this global intelligence firm.